Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
Aethlon Medical Announces Receipt of IRB Approval to Initiate Hemopurifier® Clinical Studies
Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline
TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports
ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure
First Surgery Worldwide Performed with Expanding Orthopedics' FLXfit™ 3D Expandable Interbody Cage
MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome
RVX-208 Leads to a 77% Relative Risk Reduction of Major Adverse Cardiovascular Events (MACE) in Patients with Diabetes Mellitus English English
Novel Approach to Hysterectomy Surgery Preserves Vital Support Structures, Reduces Hospital Stay and Minimizes Complications
ESC Hot Line: Data Reports NVAF Patients Taking Pradaxa® (dabigatran etexilate mesylate) Experienced Slower Decline in Kidney Function Compared to Those on Warfarin
Galmed Pharmaceuticals Completes Two Chronic Toxicology Studies and Reports No Significant Adverse Events
Amgen Submits Marketing Authorization Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The European Medicines Agency
Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th
Update on the Phase III multicenter, double-blind STEP study of Ampion™ for Osteoarthritis of the Knee
Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections
Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine
Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection English
Can-Fite Reports First Six Months 2014 Results
New Data Show Once-Daily XARELTO® May Be an Alternative to Vitamin K Antagonists in Treating Atrial Fibrillation Patients Undergoing Elective Cardioversion
New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures
Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
China Human Vaccine Industry (Hepatitis B, Influenza, Rabies & Pneumonia) 2017 Forecasts
Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents
Pfenex Reports Second Quarter 2014 Results and Provides Business Update
Mast Therapeutics Announces Management Change
Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs
DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments
Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches
Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS
BloodCenter of Wisconsin Launches Erythroid Chimerism Test for Monitoring Transplanted Sickle Cell Disease Patients
Texas Children's Hospital launches immunotherapy study
Seres Health to Present Clinical Findings at ICAAC 2014 Conference
Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol
Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA
Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System
The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine
EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro® RC System DM2 ENABLE Study
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile
Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting
IBM Watson Ushers in a New Era of Data-Driven Discoveries
Heart Hospital of Austin First in Texas to Implant New Portico™ Re-sheathable Transcatheter Aortic Valve System as Part of Clinical Trial
DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
Surgery to repair a hip fracture reduces lifetime health care costs by more than $65,000 per patient, adds years of patient life quality and mobility
Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study

< Prev Next >
PR Newswire - United Business Media